Poehling Capital Management’s Atlanta Braves Holdings Series B BATRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$996K Buy
+23,337
New +$970K 0.21% 83
2020
Q2
Sell
-124,000
Closed -$2.36M 110
2020
Q1
$2.36M Buy
+124,000
New +$3.18M 1.73% 16
2019
Q3
Sell
-56,711
Closed -$1.59M 100
2019
Q2
$1.59M Buy
56,711
+880
+2% +$24.1K 1.06% 32
2019
Q1
$1.55M Sell
55,831
-315
-0.6% -$8.66K 1.13% 32
2018
Q4
$1.4M Sell
56,146
-2,380
-4% -$60.2K 1.35% 21
2018
Q3
$1.59M Buy
58,526
+12,330
+27% +$321K 1.13% 30
2018
Q2
$1.2M Buy
46,196
+13,720
+42% +$331K 1.05% 34
2018
Q1
$741K Sell
32,476
-240
-0.7% -$5.56K 0.6% 53
2017
Q4
$727K Buy
+32,716
New +$766K 0.62% 52

Other funds holding BATRK

Poehling Capital Management's BATRK Position: Q1 2026 in Review

Poehling Capital Management opened a new position in Atlanta Braves Holdings Series B (BATRK) in Q1 2026: 23,337 shares worth $996K. The stake represents 0.21% of the portfolio and ranks #83 among its holdings. This is a return to the name: Poehling Capital Management previously reported a position in BATRK as recently as Q1 2020.

Poehling Capital Management first reported a position in BATRK in Q4 2017 and has held it in 9 quarters since. The position peaked at $2.36M in Q1 2020. 309 funds tracked by Wall St. Rank hold BATRK as of Q1 2026.

  • Poehling Capital Management held 23,337 shares of Atlanta Braves Holdings Series B worth $996K as of Q1 2026.
  • Atlanta Braves Holdings Series B was a new Poehling Capital Management position in Q1 2026.
  • Atlanta Braves Holdings Series B made up 0.21% of Poehling Capital Management's portfolio in Q1 2026, its #83 holding.
  • Poehling Capital Management first reported a position in Atlanta Braves Holdings Series B in Q4 2017 and has held it in 9 quarters since.
  • Poehling Capital Management's Atlanta Braves Holdings Series B position peaked at $2.36M in Q1 2020.
  • 309 funds tracked by Wall St. Rank held Atlanta Braves Holdings Series B as of Q1 2026.

Based on Poehling Capital Management's 13F filing for Q1 2026, filed 21 Apr 2026.